Egfr Mutations In Lung Cancer - Cancer Science

Relevant Publications

Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies.

Issue Release: 2024

A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC.

Issue Release: 2024

The clinical features and prognostic implications of the co-mutated TP53 gene in advanced non-small cell lung cancer.

Issue Release: 2024

Prediction of epidermal growth factor receptor mutation subtypes in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning.

Issue Release: 2024

Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.

Issue Release: 2024

Prevalence of EGFR Mutations in Patients With Resected Stage I-III NSCLC: Results From the EARLY-EGFR Study.

Issue Release: 2024

Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect.

Issue Release: 2024

IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer.

Issue Release: 2024

The rapidly changing field of predictive biomarkers of non-small cell lung cancer.

Issue Release: 2024

Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era.

Issue Release: 2024

Comparing the Effectiveness of Afatinib and Osimertinib for Patients With PD-L1-positive -mutant Non-small Cell Carcinoma.

Issue Release: 2024

Pulsatillic acid as a potential inhibitor of protein kinase C-alpha in non-small cell lung cancer.

Issue Release: 2024

ASCO 2024: Advances in lung cancer treatments and care: A new standard of care therapy based on the results of the LAURA study underscores the need for testing for epidermal growth factor receptor (EGFR) mutations in patients with unresectable stage III lung cancer.

Issue Release: 2024

A heterogeneous tumor immune microenvironment of uncommon epidermal growth factor receptor mutant non-small cell lung cancer.

Issue Release: 2024

Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors.

Issue Release: 2024

Case report: EGFR-TKI rechallenge after osimertinib-induced interstitial lung disease: a case report and literature review.

Issue Release: 2024

Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer.

Issue Release: 2024

PD-L1 expression in patients with non-small-cell lung cancer is associated with sex and genetic alterations: A retrospective study within the Caucasian population.

Issue Release: 2024

Identification of R776H germline mutations in a patient with multifocal lung adenocarcinoma: A case report and literature review.

Issue Release: 2024

Detection of EGFR exon 20 insertion mutations in non-small cell lung cancer: implications for consistent nomenclature in precision medicine.

Issue Release: 2024

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Egfr Mutations In Lung Cancer - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics